Surmodics (SRDX) announced the successful early clinical use of its Pounce XL Thrombectomy System. The Pounce XL Thrombectomy System received FDA 510(k) clearance in September 2024, and is currently in limited market release, with full commercial launch planned following completion of the LMR.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRDX: